Monetary giants have actually made an obvious bullish carry on Novo Nordisk. Our analysis of alternatives history for Novo Nordisk NVO exposed 15 uncommon trades.
Looking into the information, we discovered 46% of traders were bullish, while 40% revealed bearish propensities. Out of all the trades we found, 5 were puts, with a worth of $438,251, and 10 were calls, valued at $746,764.
What’s The Rate Target?
Evaluating the Volume and Open Interest in these agreements, it appears that the huge gamers have actually been considering a rate window from $35.0 to $100.0 for Novo Nordisk throughout the previous quarter.
Insights into Volume & & Open Interest
Examining the volume and open interest is a tactical action in alternatives trading. These metrics clarified the liquidity and financier interest in Novo Nordisk’s alternatives at defined strike rates. The upcoming information pictures the change in volume and open interest for both calls and puts, connected to Novo Nordisk’s significant trades, within a strike cost spectrum from $35.0 to $100.0 over the preceding one month.
Novo Nordisk Choice Volume And Open Interest Over Last thirty days
Substantial Alternatives Trades Discovered:
| Sign | PUT/CALL | Trade Type | Belief | Exp. Date | Ask | Quote | Rate | Strike Rate | Overall Trade Rate | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | PUT | SWEEP | BEARISH | 06/20/25 | $ 21.15 | $ 20.15 | $ 21.15 | $ 80.00 | $ 296.0 K | 3.8 K | 10 |
| NVO | CALL | TRADE | NEUTRAL | 01/15/27 | $ 30.75 | $ 27.1 | $ 29.0 | $ 35.00 | $ 145.0 K | 135 | 0 |
| NVO | CALL | TRADE | BEARISH | 01/16/26 | $ 27.7 | $ 27.4 | $ 27.4 | $ 35.00 | $ 137.0 K | 45 | 50 |
| NVO | CALL | SWEEP | BEARISH | 06/20/25 | $ 7.85 | $ 7.75 | $ 7.8 | $ 55.00 | $ 114.6 K | 330 | 155 |
| NVO | CALL | TRADE | NEUTRAL | 06/20/25 | $ 7.9 | $ 7.7 | $ 7.8 | $ 55.00 | $ 78.0 K | 330 | 155 |
About Novo Nordisk
With approximately one third of the international top quality diabetes treatment market, Novo Nordisk is the leading company of diabetes-care items on the planet. Based in Denmark, the business produces and markets a range of human and modern-day insulins, injectable diabetes treatments such as GLP-1 treatment, oral antidiabetic representatives, and weight problems treatments. Novo likewise has a biopharmaceutical section (making up less than 10% of profits) that concentrates on protein treatments for hemophilia and other conditions.
Due to the current alternatives history for Novo Nordisk, it’s now proper to concentrate on the business itself. We intend to explore its existing efficiency.
Present Market Standing of Novo Nordisk
- With a trading volume of 8,386,138, the cost of NVO is up by 1.78%, reaching $59.37.
- Existing RSI worths suggest that the stock is might be approaching oversold.
- Next incomes report is set up for 15 days from now.
What The Specialists State On Novo Nordisk
In the last month, 1 professionals launched rankings on this stock with a typical target cost of $64.0.
Unusual Options Activity Detected: Smart Cash on the Move
Benzinga Edge’s Unusual Options board areas prospective market movers before they occur. See what positions huge cash is handling your preferred stocks. Click on this link for gain access to
* An expert from BMO Capital has actually modified its score downward to Market Perform, changing the cost target to $64.
Trading alternatives includes higher threats however likewise provides the capacity for greater earnings. Smart traders reduce these threats through continuous education, tactical trade modifications, using different signs, and remaining attuned to market characteristics. Stay up to date with the most recent alternatives trades for Novo Nordisk with Benzinga Pro for real-time notifies.
Market News and Data gave you by Benzinga APIs